WebMD Health Corp., an Internet Brands company as well as a leader in health data services for customers, doctors and other healthcare professionals (HCPs), today announced it has signed an agreement to purchase Aptus Health.
The purchase involves the key brand of Aptus Health Univadis, a worldwide data and education platform that provides updates on medical news, conferences and research and education for 4 million HCPs in 91 nations. The transaction also involves EngagedMedia from Aptus Health, which promotes patient participation and adherence through an embedded mobile messaging platform and Tomorrow Networks, which provides data-driven, location-based mobile advertising and consumer behavior-driven marketing solutions.
The purchase will merge Aptus Health’s core competencies and scale with those of WebMD and Medscape, the flagship brands of consumers and healthcare professionals in the WebMD network.
Bob Brisco, CEO of WebMD said Aptus Health is extremely complementary to current professional as well as consumer products from WebMD, making them a great addition to their platforms. They can use their combined strengths together to extend their reach and commitment to healthcare practitioners, patients, and customers.
Adding the flagship brand of Aptus Health Univadis to the Medscape franchise will create on Medscape’s unrivaled reach as the world’s leading source of clinical news, health data, education and point-of-care instruments for health practitioners around the world.
Jeremy Schneider, Senior Vice President, and Group Manager, WebMD Global told Univadis is reinforcing its commitment to offer best-in-class content and instruments to millions of physicians around the world. They deepen their link with local markets with Univadis, extend their reach to HCP audiences and boost their value to clients.
Aptus Health, based in Reading, MA, is entirely owned by Merck, known outside the U.S. as well as Canada as MSD. As businesses build on and incorporate goods, platforms, and services, Aptus Health will continue to function as an autonomous subsidiary of WebMD.